PHOTOBIOLOGY OF VITAMIN D

维生素 D 的光生物学

基本信息

  • 批准号:
    6345222
  • 负责人:
  • 金额:
    $ 0.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-07-01 至 2002-06-30
  • 项目状态:
    已结题

项目摘要

Multiple sclerosis (MS) is a T-cell mediated autoimmune disease of the central nervous system (CNS). Much research related to the immunological aspects of MS has focused on defining the nature of the antigen(s) against which the immune response is generated and the molecule(s) responsible for presentation of these antigens. For many years, the dogma has been that T-cells recognize peptide antigens presented in the context of M11C molecules and substantial research has defined peptide antigens that may contribute to the pathogenesis of MS. Recently, it hasbeen shown that molecules of the CD1 family can act as restriction elements in lipid antigen presentations to specialized subsets of T-cells suggesting that the spectrum of antigens to which T-cells respond may be broader than previously thought. Studies on the identification of these antigens have thus far been directed only to bacterial components. CD1 glycoproteins are cell surface molecules, noncovalently linked to beta2-microglobulin and structurally related to major histocompatibility (M11C) antigens. The CD I family includes CD I a, b and c proteins, products of separate genes that all map to chromosome 1, having molecular masses of 49, 45, and 43 kDa respectively. They are found on all cortical thymocytes, but not on circulating T-cells or monocytes, and are differentially expressed by subpopulations of dendritic cells, Langerhans cells (CDI a and CD I c), subsets of B-cells (CD I c), certain T-cell leukemias, and tissue macrophages in some inflammatory lesions. In the brain, CD I a has been reported on microglia by some investigators, but not others. Battistini et al.. have shown that CDlb, is expressed in active MS lesions. Since lipids, particularly glycolipids, are a major component of the myelin membrane it is reasonable to consider that lipids may be involved in the immunopathology of MS. The immune response would include CD1 molecules presenting lipid antigens to specialized populations of T-cells. To test this hypothesis, the first step is to isolate and characterize a purified lipid antigen that elicits a T-cell response. Recent work has suggested that the glycolipids that elicit the most response contain unusual fatty acids and long chain bases. Therefore, it is important to find if unusual fatty acids or long chain bases are expressed in MS tissues.
多发性硬化症(MS)是一种t细胞介导的自身免疫性疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL F HOLICK其他文献

MICHAEL F HOLICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL F HOLICK', 18)}}的其他基金

PHOTOBIOLOGY OF VITAMIN D
维生素 D 的光生物学
  • 批准号:
    6478946
  • 财政年份:
    2000
  • 资助金额:
    $ 0.49万
  • 项目类别:
VITAMIN D3 FOR PSORIASIS
维生素 D3 治疗牛皮癣
  • 批准号:
    6306763
  • 财政年份:
    1999
  • 资助金额:
    $ 0.49万
  • 项目类别:
PHOTOBIOLOGY OF VITAMIN D
维生素 D 的光生物学
  • 批准号:
    6206417
  • 财政年份:
    1999
  • 资助金额:
    $ 0.49万
  • 项目类别:
TOPICAL 1,25 VITAMIN D3 IN CHILDREN WITH PSORIASIS
银屑病儿童局部使用 1,25 维生素 D3
  • 批准号:
    6117215
  • 财政年份:
    1998
  • 资助金额:
    $ 0.49万
  • 项目类别:
VITAMIN D3 FOR PSORIASIS
维生素 D3 治疗牛皮癣
  • 批准号:
    6117211
  • 财政年份:
    1998
  • 资助金额:
    $ 0.49万
  • 项目类别:
HEXAFLUORO 1 ALPHA 25 DIHYDROXYVITAMIN D3 & DOVONEX FOR TREATING PSORIASIS
六氟 1 ALPHA 25 二羟基维生素 D3
  • 批准号:
    6264934
  • 财政年份:
    1998
  • 资助金额:
    $ 0.49万
  • 项目类别:
TOPICAL HEXA-FLUORO 1,25-DIHYDROVITAMIN D3 IN TREATING PSORIASIS
外用六氟 1,25-二氢维生素 D3 治疗牛皮癣
  • 批准号:
    6117220
  • 财政年份:
    1998
  • 资助金额:
    $ 0.49万
  • 项目类别:
VITAMIN D AND BONE STATUS IN THE ELDERLY
老年人的维生素 D 和骨骼状况
  • 批准号:
    6233983
  • 财政年份:
    1997
  • 资助金额:
    $ 0.49万
  • 项目类别:
EVALUATION OF TOPICAL 24 EPI 1,25 DIHYDROXYVITAMIN D2
局部 24 EPI 1,25 二羟基维生素 D2 的评价
  • 批准号:
    6248479
  • 财政年份:
    1997
  • 资助金额:
    $ 0.49万
  • 项目类别:
VITAMIN D3 FOR PSORIASIS
维生素 D3 治疗牛皮癣
  • 批准号:
    6278406
  • 财政年份:
    1997
  • 资助金额:
    $ 0.49万
  • 项目类别:

相似海外基金

REU Site: University of Colorado, Engineering Smart Biomaterials
REU 站点:科罗拉多大学,工程智能生物材料
  • 批准号:
    2348856
  • 财政年份:
    2024
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Standard Grant
An iPSC based xeno-free platform to assess the foreign body response against new biomaterials
基于 iPSC 的无异源平台,用于评估新生物材料的异物反应
  • 批准号:
    NC/Y000838/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Research Grant
CAREER: Developing Ultrasound-Programmable 3D-Printed Biomaterials for Spatiotemporal Control of Gene Delivery
职业:开发用于基因传递时空控制的超声波可编程 3D 打印生物材料
  • 批准号:
    2339254
  • 财政年份:
    2024
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Continuing Grant
FET: Small: Simulation-guided design of heterochiral DNA nanostructures for biomaterials applications
FET:小型:用于生物材料应用的异手性 DNA 纳米结构的模拟引导设计
  • 批准号:
    2312215
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Standard Grant
CAREER: Surfactant Proteins that Stabilize Biomolecular Condensates: From Biophysics to Biomaterials for Biomanufacturing
职业:稳定生物分子缩合物的表面活性剂蛋白:从生物物理学到生物制造的生物材料
  • 批准号:
    2238914
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Continuing Grant
CAREER: Modular Protein Origami to Build Genetically Programmable Biomaterials
职业:用模块化蛋白质折纸构建基因可编程生物材料
  • 批准号:
    2239927
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Continuing Grant
Antimicrobial biomaterials from bio-based feedstocks with novel feedstock supplementation strategies
采用新型原料补充策略的生物基原料制成的抗菌生物材料
  • 批准号:
    10063453
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
    Collaborative R&D
Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery
小儿心脏手术中植入生物材料加速钙化和结构退化的机制
  • 批准号:
    10655959
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach
半导体生物材料加速骨骼愈合:生物工程驱动的方法
  • 批准号:
    10587508
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
Pathophysiology and prevention of degeneration of heterograft biomaterials due to advanced glycation end products and serum protein infiltration
由于晚期糖基化终产物和血清蛋白浸润导致异种移植生物材料变性的病理生理学和预防
  • 批准号:
    10679910
  • 财政年份:
    2023
  • 资助金额:
    $ 0.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了